4P G CsEGys. - Complete Information & Details

Web Reference: About Us Established in 2014, 4P-Pharma is a clinical stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus ... Sep 10, 2024 · Lille & Paris, September 10th, 2024 - 4P-Pharma, a clinical-stage startup based in Lille that develops disease-modifying therapies for untreated serious diseases, is delighted to welcome Marina Vasiliou, Christian Bechon, and Alain Sainsot as independent and non-executive members to its Board of Directors.These novel additions will strengthen 4P-Pharma's goal to become a commercial-stage ... Jan 8, 2026 · This important milestone supports the global rollout of the clinical program across Europe, Canada, and the United States, and further reinforces 4P-Pharma’s commitment to advancing disease-modifying therapies for osteoarthritis. Read the full press release: 4Moving Biotech receives FDA IND Clearance

Updated net worth Wealth Analysis and exclusive private media for 4P G CsEGys..